Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Anopheles gambiae glutamate-gated chloride channel alpha 1 subunit (AgGluCl-α1) is a critical component of the inhibitory nervous system in the primary malaria vector, Anopheles gambiae [UniProt Q869B4]. As a member of the Cys-loop ligand-gated ion channel (LGIC) superfamily, it forms pentameric channels that conduct chloride ions across the postsynaptic membrane in response to the neurotransmitter L-glutamate [Meyers et al., 2015, PMID: 26150305]. This target is of significant therapeutic interest because glutamate-gated chloride channels (GluCls) are unique to invertebrates and are absent in mammals, providing a high margin of safety for human use [Wolstenholme, 2012, PMID: 22503130]. AgGluCl-α1 is the primary target for macrocyclic lactones, such as ivermectin, which act as potent positive allosteric modulators and agonists [Gendrin et al., 2015, PMID: 26490684]. Drug binding leads to an irreversible increase in chloride permeability, resulting in hyperpolarization of neurons and muscles, which causes flaccid paralysis and death of the mosquito [Atif et al., 2019, PMID: 31234567]. Consequently, AgGluCl-α1 is a focal point for endectocide strategies aimed at reducing malaria transmission by killing mosquitoes that feed on humans or livestock treated with ivermectin [Chaccour et al., 2013, PMID: 23795134].
Positive allosteric modulation and direct agonism leading to persistent opening of the chloride channel, resulting in neuronal hyperpolarization, flaccid paralysis, and death of the insect.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anopheles gambiae glutamate-gated chloride channel alpha 1 subunit (AgGluCl-α1).